Medical Device Outsourcing Market Report 2025

The medical device outsourcing market size has grown rapidly in recent years. It will grow from $144.86 billion in 2024 to $163.1 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to increasing complexity in medical devices, cost-effective manufacturing solutions, focus on core competencies, globalization of markets, rise in contract research and development (R&D).

The medical device outsourcing market size is expected to see rapid growth in the next few years. It will grow to $290.76 billion in 2029 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to focus on core competencies, shortened time-to-market demands, cost-efficiency in production, demand for scalability and flexibility, growing complexity of medical devices. Major trends in the forecast period include rise in customization and personalization, focus on risk mitigation and compliance, growing demand for remote monitoring devices, increased emphasis on data security, innovation in wearable medical devices.

The increasing prevalence of chronic diseases is expected to drive the growth of the medical device outsourcing market. Chronic diseases are long-lasting conditions that require ongoing medical attention and can limit daily activities. The rising incidence of chronic diseases is leading to a higher demand for high-quality medical products that can be developed and launched more quickly, thus fueling the expansion of the medical device outsourcing market. For example, according to the UN Chronicle, a digital magazine of the United Nations, the global burden of chronic diseases is projected to reach approximately 56% by 2030. Therefore, the growing prevalence of chronic diseases is anticipated to be a significant driver of growth in the medical device outsourcing market.

The increasing demand for remote patient monitoring (RPM) devices is expected to drive the growth of the medical device outsourcing market in the coming years. Remote patient monitoring devices are technical instruments that collect and transmit health-related information from patients in their homes or other remote locations to healthcare practitioners. These devices rely on medical device outsourcing for the development and production of connected gadgets, sensors, and data analytics, enabling healthcare practitioners to remotely monitor patients' health conditions and enhance care delivery. For example, according to the American Medical Association in September 2022, the percentage of physicians using remote monitoring devices increased to 30% in 2022. Tele-visits were the most preferred digital health tools among physicians, with 57% expressing enthusiasm, followed closely by remote monitoring devices, which garnered approval from 53% of physicians. Therefore, the growing demand for remote patient monitoring devices is a key driver behind the growth of the medical device outsourcing market.

Strategic partnerships and collaborations are increasingly becoming a prominent trend in the medical device outsourcing market. Major companies in the industry are prioritizing partnerships and collaborations as a strategic approach to leading the market. For instance, in July 2023, Medical Device, Inc., a US-based contract manufacturing company of medical devices, acquired NextPhase Medical Devices LLC, a Mexico-based manufacturing company of medical devices. This acquisition resulted in a doubling of NextPhase's size, positioning it as a top-tier global medical device contract manufacturer, with 70% of its revenue derived from the United States. The combined entity, known as the United Group, now operates seven well-capitalized end-to-end production sites across North America, Europe, and North Africa. It boasts a diverse range of manufacturing capabilities and has substantial exposure to international markets.

Major companies in the medical device outsourcing market are focusing on innovative products, such as platforms for creating new medical devices, to better serve their existing consumers. These platforms aim to streamline the process from design to device, enabling businesses to iterate in weeks rather than months and with minimal upfront costs. For example, in March 2023, Science Corporation, a US-based biotechnology company, introduced Science Foundry. Science Foundry is a platform that grants firms access to over 80 of Science's internal products and services, including thin-film electrode technology. This platform is designed to support startups working on ambitious concepts and is expected to attract interest from neurotechnology businesses, as well as other medical technology companies and even quantum computing startups, offering growth opportunities.

In September 2024, Sanner Group, a Germany-based manufacturer of packaging and containers for drugs and medical devices, acquired Gilero LLC for an undisclosed amount. This acquisition allows Sanner to expand its capabilities and global presence, particularly in key biopharma and medtech markets. The move enhances collaboration, strengthens the supply chain, and improves service offerings, ensuring high-quality support throughout the product development process. Gilero LLC is a US-based medical equipment manufacturing company specializing in medical device outsourcing.

Major companies operating in the medical device outsourcing market include Cardinal Health Inc., Flex Ltd., Te Connectivity Ltd., Sanmina Corporation, Celestica Inc., WuXi AppTec Inc., Phillips-Medisize LLC, Intertek Group plc, Plexus Corp, Nipro Medical Corporation, Teleflex Incorporated, Integer Holdings Corporation, Cantel Medical Corp, Sterigenics International LLC, Nortech Systems Incorporated, Toxikon Inc., North American Science Associates Inc, Omnica Corp, NAMSA, Tecomet Inc., Viant Medical.

North America was the largest region in the medical device outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Medical device outsourcing is a process in which a company contracts out the manufacturing of a medical device to another company, often to leverage specialized expertise or to streamline production processes.

In medical device outsourcing, the main types of products are finished goods, electronics, and raw materials. Finished goods are products that have completed the manufacturing process but have not yet been sold or distributed to consumers. The medical devices are categorized into class I, class II, and class III devices, each with different regulatory requirements and risk levels. Medical device outsourcing services include quality assurance, regulatory affairs services, product design and development, product testing and sterilization, product implementation, product upgrade, product maintenance, and contract manufacturing. These services cater to various applications in the medical industry, including drug delivery, dental care, diabetes management, cardiology, endoscopy, in vitro diagnostics (IVD), ophthalmic devices, diagnostic imaging, orthopedics, and general and plastic surgery.

The medical device outsourcing market research report is one of a series of new reports that provides medical device outsourcing market statistics, including medical device outsourcing industry global market size, regional shares, competitors with a medical device outsourcing market share, detailed medical device outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device outsourcing industry. This medical device outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical device outsourcing market includes revenues earned by entities by providing services such as design and development. Components and devices manufacturing, process validation and verification, Packaging, regulatory consultation, and full services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.